Edition:
United Kingdom

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,342.95INR
7:20am GMT
Change (% chg)

Rs32.30 (+1.40%)
Prev Close
Rs2,310.65
Open
Rs2,325.00
Day's High
Rs2,349.00
Day's Low
Rs2,316.45
Volume
315,530
Avg. Vol
780,886
52-wk High
Rs3,203.85
52-wk Low
Rs1,901.15

Select another date:

Fri, Dec 1 2017

BRIEF-Dr.Reddy's Labs Gets EIR From U.S. FDA ‍​For Facility In Hyderabad

* SAYS GETS EIR FROM U.S. FDA ‍​FOR CUSTOM PHARMA SERVICES FACILITY IN HYDERABAD Source text - http://bit.ly/2ANfrXj Further company coverage:

BRIEF-Dr.Reddy's Labs Gets U.S. FDA Nod For Psoriasis Treatment

* SAYS CO, THROUGH UNIT, GETS NDA NOD FOR PSORIASIS TREATMENT Source text: http://bit.ly/2kd95cA Further company coverage:

BRIEF-Dr.Reddy's Laboratories gets German Regulator's Nod For CAPA Plan

* SAYS GERMAN REGULATOR PERMITTED PRODUCTION TO START AGAIN FROM FACILITY FOR EU MARKET‍​

BRIEF-Dr.Reddy's Labs Says U.S. Securities Classs Action Lawsuit Been Served On Co

* SAYS U.S. SECURITIES CLASSS ACTION LAWSUIT BEEN SERVED ON CO BY LAWFIRM REPRESENTING INVESTORS IN CO Source text - http://bit.ly/2zOAdWp Further company coverage:

BRIEF-Dr.Reddy's Laboratories gets EIR from US FDA for Duvvada facility

* Says got EIR from US FDA for formulations manufacturing facility at Duvvada, Vishakhapatnam‍​

BRIEF-Dr.Reddy's Labs ‍launches clofarabine injection in U.S.

* Says ‍launch of clofarabine injection in U.S. market​ Source text: http://bit.ly/2zBoR7i Further company coverage:

BRIEF-DR. REDDY'S LABORATORIES LAUNCHES GENERIC AZACITIDINE FOR INJECTION IN CANADIAN MARKET

* DR REDDY'S LABORATORIES ANNOUNCES THE LAUNCH OF GENERIC AZACITIDINE FOR INJECTION IN THE CANADIAN MARKET

BRIEF-India's Dr.Reddy's Laboratories Sept-qtr consol PAT down about 1 pct

* Sept quarter consol net profit after tax 3.05 billion rupees versus 3.09 billion rupees last year

BRIEF-Enorama Pharma ‍starts cooperation with Dr. Reddy's Laboratories

* ‍STARTS COOPERATION WITH DR. REDDY'S LABORATORIES ON SALES IN NORTH AMERICA​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Dr.Reddy's Labs gets EIR from U.S. FDA for plant in Andhra Pradesh

* Says gets EIR from U.S. FDA for formulation Srikakulam plant (SEZ) unit 1, Andhra Pradesh Source text - http://bit.ly/2wleXS9 Further company coverage:

Select another date: